Joel Neoh
Ex-Fave boss Joel Neoh joins NASDAQ-listed HealthTech firm Prenetics
Prenetics is a genomics and precision oncology company dedicated to transforming patient care through advanced genomic and molecular technologies.
June 6, 2023
GoTo shareholders approve appointment of Hans Patuwo as Group CEO
December 17, 2025
GoTo shareholders approve appointment of Hans Patuwo as Group CEO
December 17, 2025




